Larimar Therapeutics, Inc.
LRMR
$3.47
$0.3511.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 175.44M | 138.52M | 157.53M | 183.45M | 203.71M |
| Total Receivables | 1.00M | 983.00K | 1.06M | 1.05M | 943.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.79M | 6.05M | 6.90M | 10.80M | 8.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 183.22M | 145.56M | 165.49M | 195.30M | 213.26M |
|
|
|||||
| Total Current Assets | 183.22M | 145.56M | 165.49M | 195.30M | 213.26M |
| Net Property, Plant & Equipment | 2.98M | 3.27M | 3.50M | 3.72M | 3.81M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.15M | 1.17M | 1.19M | 1.20M | 1.96M |
| Total Assets | 187.35M | 149.99M | 170.18M | 200.23M | 219.02M |
|
|
|||||
| Total Accounts Payable | 11.10M | 4.17M | 2.27M | 2.42M | 1.69M |
| Total Accrued Expenses | 32.87M | 21.35M | 18.76M | 20.87M | 13.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.15M | 1.13M | 1.10M | 1.06M | 1.03M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 45.12M | 26.65M | 22.13M | 24.36M | 16.29M |
|
|
|||||
| Total Current Liabilities | 45.12M | 26.65M | 22.13M | 24.36M | 16.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.20M | 3.49M | 3.77M | 4.06M | 4.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 48.31M | 30.13M | 25.90M | 28.41M | 20.62M |
|
|
|||||
| Common Stock & APIC | 511.31M | 444.48M | 442.66M | 440.82M | 438.38M |
| Retained Earnings | -372.33M | -324.62M | -298.44M | -269.16M | -240.33M |
| Treasury Stock & Other | 66.00K | -9.00K | 54.00K | 148.00K | 358.00K |
| Total Common Equity | 139.04M | 119.85M | 144.27M | 171.81M | 198.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.04M | 119.85M | 144.27M | 171.81M | 198.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 139.04M | 119.85M | 144.27M | 171.81M | 198.40M |
|
|
|||||